Dow Up 1.29% Nasdaq Up 1.47%

Incyte Corporation (INCY)

-NasdaqGS
54.76 Up 2.29(4.36%) 3:25PM EDT - Nasdaq Real Time Price
Prev Close:52.47
Open:53.02
Bid:54.76 x 200
Ask:54.78 x 200
1y Target Est:75.15
Beta:-0.13
Next Earnings Date:30-Oct-14INCY Earnings announcement
Day's Range:52.38 - 55.15
52wk Range:35.21 - 70.86
Volume:758,313
Avg Vol (3m):948,545
Market Cap:9.22B
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INCY

Comparison

Symbol% ChgMkt Cap
INCYUp 4.36%9.22B
AMGNUp 2.23%111.54B
CELGUp 5.57%79.98B
RHHBYUp 0.78%248.97B

Key Statistics

Forward P/E (1 yr):219.04
P/S (ttm):23.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.39
Quarterly EPS Est (Sep-14) :0.00
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback